Page last updated: 2024-08-21
dexamethasone 21-phosphate and Glial Cell Tumors
dexamethasone 21-phosphate has been researched along with Glial Cell Tumors in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Foreman, NK; Liu, AK; Macy, ME | 1 |
Labadie, EL; Oommen, KJ; Smith, MS | 1 |
Other Studies
2 other study(ies) available for dexamethasone 21-phosphate and Glial Cell Tumors
Article | Year |
---|---|
Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain; Brain Neoplasms; Child; Dexamethasone; Fatal Outcome; Female; Glioma; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Necrosis; Pons; Quality of Life; Radiation Injuries; Radiosurgery; Treatment Outcome; Vascular Endothelial Growth Factor A | 2009 |
Pontine hemorrhage causing Fisher one-and-a-half syndrome with facial paralysis.
Topics: Brain Neoplasms; Cerebral Hemorrhage; Dexamethasone; Diagnosis, Differential; Diplopia; Facial Paralysis; Glioma; Humans; Male; Middle Aged; Pons; Syndrome; Tomography, X-Ray Computed | 1982 |